Nihon Kohden (OTCMKTS:NHNKY) Shares Up 7.9% – Time to Buy?

Nihon Kohden Corporation (OTCMKTS:NHNKY) shares shot up 7.9% on Monday . The stock traded as high as $9.44 and last traded at $9.40. 2,946 shares changed hands during trading, a decline of 90% from the average session volume of 29,891 shares. The stock had previously closed at $8.71.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. UBS Group raised Nihon Kohden from a “hold” rating to a “strong-buy” rating in a research report on Monday, January 19th. Zacks Research upgraded Nihon Kohden to a “hold” rating in a research note on Monday, April 27th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, Nihon Kohden has a consensus rating of “Buy”.

Nihon Kohden Trading Up 0.8%

The firm has a fifty day simple moving average of $9.44 and a 200-day simple moving average of $10.49. The stock has a market cap of $1.60 billion, a price-to-earnings ratio of 15.90 and a beta of 0.41.

Nihon Kohden (OTCMKTS:NHNKY) last posted its quarterly earnings results on Thursday, May 14th. The company reported $0.34 earnings per share for the quarter, beating analysts’ consensus estimates of $0.24 by $0.10. The company had revenue of $453.10 million for the quarter, compared to the consensus estimate of $414.40 million. Nihon Kohden had a return on equity of 9.48% and a net margin of 6.08%. On average, equities analysts predict that Nihon Kohden Corporation will post 0.61 earnings per share for the current fiscal year.

Nihon Kohden Company Profile

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.